High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.9M
$2,856,271
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -76.0%
2026-02-20
$218,270x2
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -76.0%
|
2026-02-20 | $218,270x2 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-01-20 | $373,521x3 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -52.6%
2025-12-17
$2,264,480Largex4
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -52.6%
|
2025-12-17 | $2,264,480Largex4 | S | Form 4 |